查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1463045

人类生长激素市场、占有率、规模、趋势、产业分析报告：依类型、给药途径、年龄、适应症、分销管道、地区、细分市场预测，2024-2032 年

Human Growth Hormone Market Share, Size, Trends, Industry Analysis Report, By Type (Long-acting, Short-acting & Intermediate-acting); By Route of Administration; By Age; By Indication; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 114 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2032年，全球人类生长激素市场规模预计将达到156.6亿美元。 该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

人类生长激素 (HGH) 市场的范围涵盖了定义其范围、应用和影响因素的各个维度。 该市场致力于 HGH 的治疗用途，解决儿童和成人生长激素缺乏症等医疗状况。 HGH 用于刺激内源性生长激素分泌不足的人的生长和发育。

市场的很大一部分专注于解决儿童生长障碍，包括由于生长激素缺乏而导致身材矮小等疾病。 HGH 疗法是促进儿童线性生长的常见疗法。 该市场也扩大到包括生长激素缺乏症的成年人，其中 HGH 用于治疗 AGHD 等疾病。 这包括解决成年期间与生长激素缺乏相关的健康问题。 市场上也有越来越多的领域涉及抗衰老和健康应用。 HGH 有时也因其明显的抗衰老作用而被使用，包括改善皮肤健康、能量水平和整体健康。

此外，HGH也用于治疗肌肉无力和代谢紊乱。 市场正在解决 HGH 的治疗用途，以减轻特定患者群体肌肉损失的影响并改善代谢功能。

生长激素缺乏症(GHD) 的高盛行率、由于与GHD 相关的严重风险而促使的治疗需求不断增加，以及对减少注射频率的药物的需求不断增长，正在推动人类生长激素市场的发展，这是导致这一问题的主要因素。

脑下垂体功能不全病例数量的增加以及为提高患者治疗依从性而开发更先进技术的市场等因素也促进了市场的成长。 产业参与者对研发活动的日益关注，再加上生长激素的强大管道，预计将在预测期内推动市场成长。

对适当治疗的认识不断提高，以及公共和私人组织在治疗人类生长缺陷方面不断采取的举措，预计将有利于人类生长激素市场的扩张。 此外，新兴国家受罕见疾病影响的患者数量不断增加也将有助于市场发展。

人类生长激素市场报告亮点

由于长效人类生长激素的安全性和有效性，预计长效细分市场在预测期内将以最高复合年增长率扩张。

2023 年，由于疾病的高盛行率以及治疗该疾病的新产品数量不断增加，生长激素缺乏症领域占了最大的市场占有率。

2023年，由于就诊医院的病患数量不断增加，医院药局部门占了最大的市场占有率。

由于特纳氏症和生长激素缺乏症病例的增加，2023 年北美在人类生长激素市场中占最大的收入占有率。

市场参与者包括AnkeBio Co., Ltd.、Ascendis Pharma、Novo Nordisk、Pfizer、Eli Lilly、Sandoz International、Merck、Genentech等。

目录

第一章简介

第 2 章执行摘要

第三章研究方法

第四章全球人类生长激素市场洞察

  • 人类生长激素 - 产业概况
  • 人类生长激素市场动态
    • 推动者和机会
      • 生长激素缺乏症和其他疾病的盛行率增加
      • 研发活动增加
    • 抑制因素和课题
      • 副作用与安全性问题
  • 杵分析
  • 人类生长激素产业的趋势
  • 新冠肺炎 (COVID-19) 影响分析

第 5 章世界市场（依类型）

  • 主要发现
  • 简介
  • 长效
  • 短效与中效

第 6 章依管理途径划分的全球市场

  • 主要发现
  • 简介
  • 口头
  • 注射用

第 7 章依年龄划分的世界市场

  • 主要发现
  • 简介
  • 儿童
  • 成人

第 8 章依通路划分的世界市场

  • 主要发现
  • 简介
  • 医院药房
  • 零售药局/药局
  • 网路药局

第 9 章依适应症划分的全球市场

  • 主要发现
  • 简介
  • 生长激素缺乏
  • 特纳氏症
  • 特发性身材矮小
  • 普拉德-威利症候群
  • 其他

第 10 章依地区划分的世界市场

  • 主要发现
  • 简介
    • 2019-2032 年人类生长激素市场评估（依地区）
  • 人类生长激素市场 - 北美
    • 北美：人类生长激素市场（依类型），2019-2032 年
    • 北美：人类生长激素市场，依通路划分，2019-2032 年
    • 北美：人类生长激素市场（依给药途径），2019-2032 年
    • 北美：人类生长激素市场，依年龄划分，2019-2032 年
    • 北美：人类生长激素市场，依适应症划分，2019-2032 年
    • 人类生长激素市场 - 美国
    • 人类生长激素市场 - 加拿大
  • 人类生长激素市场 - 欧洲
    • 欧洲：人类生长激素市场（依类型），2019-2032 年
    • 欧洲：人类生长激素市场，依通路划分，2019-2032 年
    • 欧洲：人类生长激素市场（依给药途径），2019-2032 年
    • 欧洲：人类生长激素市场，依年龄划分，2019-2032 年
    • 欧洲：人类生长激素市场，依适应症划分，2019-2032 年
    • 人类生长激素市场 - 英国
    • 人类生长激素市场 - 法国
    • 人类生长激素市场 - 德国
    • 人类生长激素市场 - 义大利
    • 人类生长激素市场 - 西班牙
    • 人类生长激素市场 - 荷兰
    • 人类生长激素市场 - 俄罗斯
  • 人类生长激素市场 - 亚太地区
    • 亚太地区：人类生长激素市场，依类型，2019-2032 年
    • 亚太地区：人类生长激素市场，依通路划分，2019-2032 年
    • 亚太地区：人类生长激素市场（依给药途径），2019-2032 年
    • 亚太地区：人类生长激素市场，依年龄划分，2019-2032 年
    • 亚太地区：人类生长激素市场，依指标划分，2019-2032 年
    • 人类生长激素市场 - 中国
    • 人类生长激素市场 - 印度
    • 人类生长激素市场 - 日本
    • 人类生长激素市场 - 马来西亚
    • 人类生长激素市场 - 印尼
    • 人类生长激素市场 - 韩国
  • 人类生长激素市场 - 中东和非洲
    • 中东和非洲：人类生长激素市场（依类型），2019-2032 年
    • 中东和非洲：人类生长激素市场，依分销管道划分，2019-2032 年
    • 中东和非洲：人类生长激素市场（依给药途径），2019-2032 年
    • 中东与非洲：人类生长激素市场，依年龄划分，2019-2032 年
    • 中东与非洲：人类生长激素市场，依指标划分，2019-2032 年
    • 人类生长激素市场 - 沙乌地阿拉伯
    • 人类生长激素市场 - 阿联酋
    • 人类生长激素市场 - 以色列
    • 人类生长激素市场 - 南非
  • 人类生长激素市场 - 拉丁美洲
    • 拉丁美洲：人类生长激素市场，依类型，2019-2032 年
    • 拉丁美洲：人类生长激素市场，依通路划分，2019-2032 年
    • 拉丁美洲：人类生长激素市场（依给药途径），2019-2032 年
    • 拉丁美洲：人类生长激素市场，依年龄划分，2019-2032 年
    • 拉丁美洲：人类生长激素市场，依适应症划分，2019-2032 年
    • 人类生长激素市场 - 墨西哥
    • 人类生长激素市场 - 巴西
    • 人类生长激素市场 - 阿根廷

第十一章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 合作/协作/合约/出版物

第十二章公司简介

  • AnkeBio Co., Ltd
  • Ascendis Pharma
  • Eli Lilly and Company
  • Ferring Pharmaceuticals
  • Genentech, Inc（Roche）
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk
  • Pfizer Inc.
  • Sandoz International GmbH
Product Code: PM4705

The global human growth hormone market size is expected to reach USD 15.66 billion by 2032, according to a new study by Polaris Market Research. The report "Human Growth Hormone Market Share, Size, Trends, Industry Analysis Report, By Type (Long-acting, Short-acting & Intermediate-acting); By Route of Administration; By Age; By Indication; By Distribution Channel; By Region; Segment Forecast, 2023- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The scope of the Human Growth Hormone (HGH) market encompasses various dimensions that define its reach, applications, and influencing factors. The market caters to therapeutic applications of HGH, addressing medical conditions such as growth hormone deficiencies in children and adults. HGH is used to stimulate growth and development in individuals with insufficient endogenous growth hormone production.

A significant portion of the market focuses on addressing pediatric growth disorders, including conditions like short stature due to growth hormone deficiencies. HGH therapy is a common intervention to promote linear growth in children. The market extends its scope to adults with growth hormone deficiencies, where HGH is used to address conditions such as AGHD. This involves addressing health issues associated with insufficient growth hormone production in adulthood. There is a growing segment within the market that caters to anti-aging and wellness applications. HGH is sometimes used for its perceived anti-aging effects, including improvements in skin health, energy levels, and overall well-being.

Furthermore, HGH is employed in the treatment of muscle-wasting conditions and metabolic disorders. The market addresses the therapeutic use of HGH to mitigate the effects of muscle loss and improve metabolic functions in certain patient populations.

The high prevalence of growth hormone deficiency (GHD), the increasing need for treatment owing to serious risks associated with GHD, and the rising demand for medications that reduce the frequency of injections are the major factors contributing to the growth of the human growth hormone market.

Factors such as increasing cases of pituitary dysfunction and the development of more advanced technologies to enhance patient adherence to the treatment contribute to the market growth. The rising emphasis of industry players on research & development activities coupled with the strong pipeline of somatropin is expected to drive the market growth during the forecast period.

Increasing awareness related to appropriate treatment coupled with the growing initiatives by public and private organizations related to the treatment of human growth deficiency are expected to prove beneficial for the expansion of the human growth hormone market. Moreover, the increasing number of patients suffering from rare diseases across developing countries will also contribute to the market growth.

Human Growth Hormone Market Report Highlights

The long-acting segment is projected to expand at the highest CAGR during the forecast period, owing to the safety profile & effectiveness of long-acting human growth hormones.

In 2023, the growth hormone deficiency segment accounted for the largest market share, owing to the high prevalence of the disease and the rising number of new products for its treatment.

In 2023, the hospital pharmacies segment accounted for the largest market share, owing to the increasing number of patient visits to hospitals.

North America accounted for the largest revenue share in the human growth hormone market in 2023, owing to the rising cases of Turner syndrome and growth hormone deficiencies.

The market players include AnkeBio Co., Ltd, Ascendis Pharma, Novo Nordisk, Pfizer, Eli Lilly, Sandoz International, Merck, Genentech, and more.

Polaris Market Research has segmented the human growth hormone market report based on type, route of administration, age, indication, distribution channel, and region:

Human Growth Hormone, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Long-acting
  • Short-acting & Intermediate-acting

Human Growth Hormone, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Oral
  • Parenteral
  • Intravenous
  • Subcutaneous
  • Intramuscular

Human Growth Hormone, Age Outlook (Revenue - USD Billion, 2019 - 2032)

  • Pediatric
  • Adult

Human Growth Hormone, Indication Outlook (Revenue - USD Billion, 2019 - 2032)

  • Growth Hormone Deficiency
  • Turner Syndrome
  • Idiopathic Short Stature
  • Prader-Willi Syndrome
  • Others

Human Growth Hormone, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacies
  • Retail Pharmacies & Drug Stores
  • Online Pharmacies

Human Growth Hormone, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of LA
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Human Growth Hormone Market Insights

  • 4.1. Human Growth Hormone - Industry Snapshot
  • 4.2. Human Growth Hormone Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Growth Hormone Deficiency and Other Disorders
      • 4.2.1.2. Growing Number of Research & Development Activities
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Side Effects and Safety Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Human Growth Hormone Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Human Growth Hormone Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Long-acting
    • 5.3.1. Global Human Growth Hormone Market, by Long-acting, by Region, 2019-2032 (USD Billion)
  • 5.4. Short-acting & Intermediate-acting
    • 5.4.1. Global Human Growth Hormone Market, by Short-acting & Intermediate-acting, by Region, 2019-2032 (USD Billion)

6. Global Human Growth Hormone Market, by Route of Administration

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • 6.3. Oral
    • 6.3.1. Global Human Growth Hormone Market, by Oral, by Region, 2019-2032 (USD Billion)
  • 6.4. Parenteral
    • 6.4.1. Global Human Growth Hormone Market, by Parenteral, by Region, 2019-2032 (USD Billion)
    • 6.4.2. Intravenous
      • 6.4.2.1. Global Human Growth Hormone Market, by Intravenous, by Region, 2019-2032 (USD Billion)
    • 6.4.3. Subcutaneous
      • 6.4.3.1. Global Human Growth Hormone Market, by Subcutaneous, by Region, 2019-2032 (USD Billion)
    • 6.4.4. Intramuscular
      • 6.4.4.1. Global Human Growth Hormone Market, by Intramuscular, by Region, 2019-2032 (USD Billion)

7. Global Human Growth Hormone Market, by Age

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • 7.3. Pediatric
    • 7.3.1. Global Human Growth Hormone Market, by Pediatric, by Region, 2019-2032 (USD Billion)
  • 7.4. Adult
    • 7.4.1. Global Human Growth Hormone Market, by Adult, by Region, 2019-2032 (USD Billion)

8. Global Human Growth Hormone Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.3. Hospital Pharmacies
    • 8.3.1. Global Human Growth Hormone Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Billion)
  • 8.4. Retail Pharmacies & Drug Stores
    • 8.4.1. Global Human Growth Hormone Market, by Retail Pharmacies & Drug Stores, by Region, 2019-2032 (USD Billion)
  • 8.5. Online Pharmacies
    • 8.5.1. Global Human Growth Hormone Market, by Online Pharmacies, by Region, 2019-2032 (USD Billion)

9. Global Human Growth Hormone Market, by Indication

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • 9.3. Growth Hormone Deficiency
    • 9.3.1. Global Human Growth Hormone Market, by Growth Hormone Deficiency, by Region, 2019-2032 (USD Billion)
  • 9.4. Turner Syndrome
    • 9.4.1. Global Human Growth Hormone Market, by Turner Syndrome, by Region, 2019-2032 (USD Billion)
  • 9.5. Idiopathic Short Stature
    • 9.5.1. Global Human Growth Hormone Market, by Idiopathic Short Stature, by Region, 2019-2032 (USD Billion)
  • 9.6. Prader-Willi Syndrome
    • 9.6.1. Global Human Growth Hormone Market, by Prader-Willi Syndrome, by Region, 2019-2032 (USD Billion)
  • 9.7. Others
    • 9.7.1. Global Human Growth Hormone Market, by Others, by Region, 2019-2032 (USD Billion)

10. Global Human Growth Hormone Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. Human Growth Hormone Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 10.3. Human Growth Hormone Market - North America
    • 10.3.1. North America: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
    • 10.3.2. North America: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.3.3. North America: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.3.4. North America: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
    • 10.3.5. North America: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.3.6. Human Growth Hormone Market - U.S.
      • 10.3.6.1. U.S.: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.3.6.2. U.S.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.3.6.3. U.S.: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.3.6.4. U.S.: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.3.6.5. U.S.: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.3.7. Human Growth Hormone Market - Canada
      • 10.3.7.1. Canada: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.3.7.2. Canada.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.3.7.3. Canada: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.3.7.4. Canada: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.3.7.5. Canada: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • 10.4. Human Growth Hormone Market - Europe
    • 10.4.1. Europe: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
    • 10.4.2. Europe.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.4.3. Europe: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.4.4. Europe: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
    • 10.4.5. Europe: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.6. Human Growth Hormone Market - UK
      • 10.4.6.1. UK: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.6.2. UK.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.6.3. UK: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.6.4. UK: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.6.5. UK: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.7. Human Growth Hormone Market - France
      • 10.4.7.1. France: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.7.2. France.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.7.3. France: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.7.4. France: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.7.5. France: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.8. Human Growth Hormone Market - Germany
      • 10.4.8.1. Germany: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.8.2. Germany.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.8.3. Germany: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.8.4. Germany: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.8.5. Germany: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.9. Human Growth Hormone Market - Italy
      • 10.4.9.1. Italy: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.9.2. Italy.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.9.3. Italy: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.9.4. Italy: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.9.5. Italy: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.10. Human Growth Hormone Market - Spain
      • 10.4.10.1. Spain: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.10.2. Spain.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.10.3. Spain: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.10.4. Spain: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.10.5. Spain: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.11. Human Growth Hormone Market - Netherlands
      • 10.4.11.1. Netherlands: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.11.2. Netherlands.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.11.3. Netherlands: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.11.4. Netherlands: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.11.5. Netherlands: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.12. Human Growth Hormone Market - Russia
      • 10.4.12.1. Russia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.12.2. Russia.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.12.3. Russia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.12.4. Russia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.12.5. Russia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • 10.5. Human Growth Hormone Market - Asia Pacific
    • 10.5.1. Asia Pacific: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
    • 10.5.2. Asia Pacific.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.5.3. Asia Pacific: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.5.4. Asia Pacific: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
    • 10.5.5. Asia Pacific: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.6. Human Growth Hormone Market - China
      • 10.5.6.1. China: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.6.2. China.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.6.3. China: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.6.4. China: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.6.5. China: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.7. Human Growth Hormone Market - India
      • 10.5.7.1. India: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.7.2. India.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.7.3. India: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.7.4. India: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.7.5. India: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.8. Human Growth Hormone Market - Japan
      • 10.5.8.1. Japan: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.8.2. Japan.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.8.3. Japan: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.8.4. Japan: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.8.5. Japan: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.9. Human Growth Hormone Market - Malaysia
      • 10.5.9.1. Malaysia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.9.2. Malaysia.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.9.3. Malaysia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.9.4. Malaysia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.9.5. Malaysia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.10. Human Growth Hormone Market - Indonesia
      • 10.5.10.1. Indonesia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.10.2. Indonesia.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.10.3. Indonesia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.10.4. Indonesia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.10.5. Indonesia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.11. Human Growth Hormone Market - South Korea
      • 10.5.11.1. South Korea: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.11.2. South Korea.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.11.3. South Korea: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.11.4. South Korea: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.11.5. South Korea: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • 10.6. Human Growth Hormone Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
    • 10.6.2. Middle East & Africa: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.6.3. Middle East & Africa: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.6.4. Middle East & Africa: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
    • 10.6.5. Middle East & Africa: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.6.6. Human Growth Hormone Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.6.6.2. Saudi Arabia.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.6.7. Human Growth Hormone Market - UAE
      • 10.6.7.1. UAE: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.6.7.2. UAE.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.6.7.3. UAE: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.7.4. UAE: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.6.7.5. UAE: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.6.8. Human Growth Hormone Market - Israel
      • 10.6.8.1. Israel: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.6.8.2. Israel.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.6.8.3. Israel: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.8.4. Israel: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.6.8.5. Israel: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.6.9. Human Growth Hormone Market - South Africa
      • 10.6.9.1. South Africa: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.6.9.2. South Africa.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.6.9.3. South Africa: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.9.4. South Africa: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.6.9.5. South Africa: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • 10.7. Human Growth Hormone Market - Latin America
    • 10.7.1. Latin America: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
    • 10.7.2. Latin America.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.7.3. Latin America: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.7.4. Latin America: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
    • 10.7.5. Latin America: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.7.6. Human Growth Hormone Market - Mexico
      • 10.7.6.1. Mexico: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.7.6.2. Mexico.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.7.6.3. Mexico: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.6.4. Mexico: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.7.6.5. Mexico: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.7.7. Human Growth Hormone Market - Brazil
      • 10.7.7.1. Brazil: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.7.7.2. Brazil.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.7.7.3. Brazil: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.7.4. Brazil: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.7.7.5. Brazil: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.7.8. Human Growth Hormone Market - Argentina
      • 10.7.8.1. Argentina: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.7.8.2. Argentina.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.7.8.3. Argentina: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.8.4. Argentina: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.7.8.5. Argentina: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. AnkeBio Co., Ltd
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Ascendis Pharma
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Eli Lilly and Company
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Ferring Pharmaceuticals
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Genentech, Inc (Roche)
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Merck KGaA
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Novartis AG
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Novo Nordisk
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Pfizer Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Sandoz International GmbH
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development

List of Tables

  • Table 1 Global Human Growth Hormone Market, by Type, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Human Growth Hormone Market, by Route of Administration, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Human Growth Hormone Market, by Age, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Human Growth Hormone Market, by Indication, by Region, 2019-2032 (USD Billion)
  • Table 5 Global Human Growth Hormone Market, by Distribution Channel, by Region, 2019-2032 (USD Billion)
  • Table 6 North America: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 7 North America: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 8 North America: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 9 North America: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 10 North America: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 11 U.S.: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 12 U.S.: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 13 U.S.: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 14 U.S.: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 15 U.S.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 16 Canada: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 17 Canada: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 18 Canada: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 19 Canada: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 20 Canada: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 21 Europe: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 22 Europe: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 23 Europe: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 24 Europe: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 25 Europe: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 Germany: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 27 Germany: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 28 Germany: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 29 Germany: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 30 Germany: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 31 France: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 32 France: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 33 France: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 34 France: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 35 France: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 36 UK: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 37 UK: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 38 UK: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 39 UK: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 40 UK: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 41 Italy: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 42 Italy: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 43 Italy: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 44 Italy: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 45 Italy: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 46 Netherlands: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 47 Netherlands: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 48 Netherlands: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 49 Netherlands: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 50 Netherlands: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 51 Spain: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Spain: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 53 Spain: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 54 Spain: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 55 Spain: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 56 Russia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 57 Russia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 58 Russia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 59 Russia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 60 Russia: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 61 Asia Pacific: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 62 Asia Pacific: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 63 Asia Pacific: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 64 Asia Pacific: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 65 Asia Pacific: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 66 China: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 67 China: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 68 China: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 69 China: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 70 China: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 71 Japan: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 72 Japan: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 73 Japan: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 74 Japan: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 75 Japan: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 76 India: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 77 India: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 78 India: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 79 India: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 80 India: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 81 Indonesia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 82 Indonesia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 83 Indonesia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 84 Indonesia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 85 Indonesia: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 86 Malaysia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 87 Malaysia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 88 Malaysia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 89 Malaysia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 90 Malaysia: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 91 South Korea: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 92 South Korea: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 93 South Korea: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 94 South Korea: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 95 South Korea: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 96 Latin America: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 97 Latin America: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 98 Latin America: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 99 Latin America: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 100 Latin America: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 101 Brazil: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 102 Brazil: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 103 Brazil: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 104 Brazil: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 105 Brazil: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 106 Mexico: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 107 Mexico: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 108 Mexico: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 109 Mexico: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 110 Mexico: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 111 Argentina: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 112 Argentina: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 113 Argentina: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 114 Argentina: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 115 Argentina: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 116 Middle East & Africa: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 117 Middle East & Africa: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 118 Middle East & Africa: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 119 Middle East & Africa: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 120 Middle East & Africa: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 121 UAE: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 122 UAE: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 123 UAE: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 124 UAE: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 125 UAE: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 126 Saudi Arabia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 127 Saudi Arabia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 128 Saudi Arabia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 129 Saudi Arabia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 130 Saudi Arabia: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 131 South Africa: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 132 South Africa: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 133 South Africa: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 134 South Africa: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 135 South Africa: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 136 Israel: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 137 Israel: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 138 Israel: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 139 Israel: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 140 Israel: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Human Growth Hormone Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Human Growth Hormone Market, by Type, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Route of Administration
  • Figure 9. Global Human Growth Hormone Market, by Route of Administration, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Age
  • Figure 11. Global Human Growth Hormone Market, by Age, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Indication
  • Figure 13. Global Human Growth Hormone Market, by Indication, 2021 & 2030 (USD Billion)
  • Figure 14. Market by Distribution Channel
  • Figure 15. Global Human Growth Hormone Market, by Distribution Channel, 2021 & 2030 (USD Billion)